Latvia Launches Aspiring plan to Combat Cancer,Boost Survival Rates
Latvia’s government approved a comprehensive healthcare plan on October 21st aimed at substantially improving cancer care and outcomes across the nation between 2025 and 2027. The initiative focuses on bolstering services throughout the entire continuum of care, from preventative measures and early detection to advanced treatment options and enhanced data management.
A Roadmap for Targeted Advancement
“action plans in health care areas are a roadmap for targeted improvement of services, availability of medicines and quality of life of patients,” a senior official stated. The plan is rooted in the understanding that strategic investment in focused healthcare measures yields significant benefits for patients, the state, and the broader economy. Recent successes in breast cancer treatment demonstrate this principle, with survival rates improving by 27% over the past 5-7 years, alongsi
These efforts have contributed to a more than 10% decrease in premature mortality from benign tumors. Currently, preparations are underway for international accreditation of the Latvian Cancer Center and the development of a regulatory framework for precision medicine, signaling a move towards highly personalized and effective cancer care.
Collaborative Development and European Alignment
The development of this ambitious plan was a collaborative effort, involving five thematically focused working groups comprised of medical professionals, patient advocacy organizations, researchers, and public representatives. Input from public consultations was also incorporated, ensuring a broad range of perspectives informed the final strategy. The plan is closely aligned with the European plan to defeat cancer, reflecting international best practices and priorities in oncology.
Addressing a Significant Public Health Challenge
Cancer remains a major public health concern in Latvia, with over 10,000 new cases diagnosed annually and more than 5,800 resulting in fatalities. The most prevalent forms of the disease include prostate cancer in men, breast cancer in women, colorectal cancer, bronchial and lung cancer, and skin cancer. While cancer incidence is lower in children and adolescents, the plan prioritizes improvements in pediatric oncology as well.
Key Objectives for 2027
The plan outlines specific, measurable goals to be achieved by 2027, including:
- achieving 75% CPV vaccination coverage among 12-year-old children.
- Increasing cancer screening coverage to 70-90% for various cancer types.
- Ensuring at least 90% of individuals invited to cancer screenings participate.
- Launching pilot programs for prostate, stomach, and lung cancer screening.
- Raising the five-year cancer survival rate to a minimum of 55%.
- Reducing cancer mortality rates to the european average.
- Securing international accreditation for the Latvian Cancer Center.
- Reducing preventable risk factors, such as smoking and alcohol consumption.
Regional Focus and Resource Allocation
Recognizing disparities in cancer incidence, mortality, and treatment access across different regions of Latvia, the plan emphasizes capacity building in underserved areas. This includes ongoing professional development for medical personnel and targeted public awareness campaigns in regions with low screening participation rates. Efforts will also focus on expanding the availability of medications, introducing innovative therapies, and increasing financial support for existing treatments.
Prevention as a Cornerstone of the Strategy
The plan recognizes that effective prevention is crucial in the fight against cancer. Public education campaigns will address key risk factors, including smoking, alcohol abuse, unhealthy diets, and physical inactivity.
To fully implement the health Care Service Improvement Plan in the field of oncology, an estimated 82.9 million euros will be required over the next three years. The implementation of planned measures will be phased, taking into account the financial resources available within the state budget.
